Literature DB >> 11545393

Peak deformation in cationic analysis caused by system zones.

J L Beckers1.   

Abstract

In electrophoretic processes, often zones migrate through the separation compartment, with a composition different from that of the background electrolyte (BGE) but which do not contain, however, any component of the sample mixture. These zones migrate with a mobility mainly determined by the composition of the BGE and are called system zones (SZs). If these SZs are visible in electropherograms they are called system peaks (SPs). If sample components have a mobility close to that of a SZ, the separation process can be disturbed and the sample peak shapes are deformed. SZs can appear applying BGEs containing more co-ionic species or if BGEs are used at high or low pH. Recently, the existence of SZs has been described applying BGEs containing weak multivalent anionic species. In this paper, the diverse kinds of system zones, are discussed for cationic systems and the effect of invisible SZs on separations is shown. As an example of a weak multivalent cation, the behavior of the divalent cation histamine is studied, which can be used as co-ion in BGEs for the separation of cations in the indirect UV mode. Applying BGEs containing histamine, SZs are visible in the electropherograms and there existence could also be established theoretically by the use of SystCharts. A mathematical model for the calculation of the mobility of SZs is verified and it has been shown that an unsafe region with a mobility window of msp +/- 10% can be indicated, for the separation of fully ionized sample components.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11545393     DOI: 10.1002/1522-2683(200108)22:13<2684::AID-ELPS2684>3.0.CO;2-C

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  1 in total

1.  Quality Assessment of Untargeted Analytical Data in a Large-Scale Metabolomic Study.

Authors:  Rintaro Saito; Masahiro Sugimoto; Akiyoshi Hirayama; Tomoyoshi Soga; Masaru Tomita; Toru Takebayashi
Journal:  J Clin Med       Date:  2021-04-22       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.